Melanoma / William Sharfman, guest editor.

Format:

Book

Contributor:

Sharfman, William.

Series:

Emerging cancer therapeutics ; 2151-4194 v. 3, issue 3.

Emerging cancer therapeutics ; v. 3, issue 3

Language:

English

Subjects (All):

Melanoma.

Melanoma--Treatment.

Melanoma--therapy.

Skin Neoplasms--therapy.

Antineoplastic Agents--therapeutic use.

Immunotherapy.

Molecular Targeted Therapy.

Medical Subjects:

Melanoma--therapy.

Skin Neoplasms--therapy.

Antineoplastic Agents--therapeutic use.

Immunotherapy.

Molecular Targeted Therapy.

Physical Description:

xv pages, 391 unnumbered pages-609 pages : illustrations (some color). ; 26 cm.

Place of Publication:

New York, NY : Demos Medical Pub., [2012]

Summary:

Emerging Cancer Therapeutics is a trinary hard cover periodical that is designed to provide an up-to-date evidence-based review of a dedicated emerging cancer therapy topic of interest to clinicians and scientists involved in the care of patients receiving cancer treatment. It will serve as both a reference and instructional tool for students, housestaff, fellows, practicing clinical oncologists, radiation oncologists, surgical oncologists, cancer biologists, and interdisciplinary colleagues throughout the oncology spectrum.

With contributions from nationally recognized experts representing the fields of dermatology, dermatologic surgery, surgical oncology, dermatopathology, and medical oncology, Melanoma includes chapters on prevention, changes in melanoma staging, the evolving role of established surgical therapies, single-agent specific V600E mutant inhibitors, target therapy for patients without BRAF mutations, new treatments for metastatic melanoma-including ipilimumab and vemurafenib-and more.

Included in Melanoma

Preventing Melanoma

Evolution of the Melanoma Staging System

Less Common Variants of Cutaneous Melanoma

Controversies in the Management of the Regional Node Basin in Cutaneous Melanoma

Adjuvant Therapy for Melanoma

RAF Kinase Inhibitor Therapy in Melanoma

Emerging Targets for Melanoma Therapy Besides BRAF

Ipilimumab: The New Frontier of T-Cell Antibodies: A Paradigm Shift in Immuno-Oncology

Adoptive Cell Transfer Immunotherapy for Patients With Metastatic Melanoma

Immunotherapies for Metastatic Melanoma

Updated Approach to the Patient With Metastatic Melanoma Book jacket.

Contents:

Preventing melanoma / Barbara Summerer, Sewon Kang, and Timothy Wang

Evolution of the melanoma staging system / Rohit R. Sharma, Glen C. Balch, and Charles M. Balch

Less common variants of cutaneous melanoma / Raymond L. Barnhill, G. Peter Sarantopoulos, and Kapil Gupta

Controversies in the management of the regional node basin in cutaneous melanoma / Ioannis Hatzaras and Julie R. Lange

Adjuvant therapy for melanoma / Tara C. Gangadhar and Lynn M. Schuchter

RAF kinase inhibitor therapy in melanoma / James J. Harding and Paul B. Chapman

Emerging targets for melanoma therapy besides BRAF / Young Kwang Chae, Sapna P. Patel, and Kevin B. Kim

Ipilimumab : the new frontier of T-cell antibodies : a paradigm shift in immuno-oncology / Steven J. O'Day

Adoptive cell transfer immunotherapy for patients with metastatic melanoma / Crystal J. Hessman ... [et al.]

Immunotherapies for metastatic melanoma / Kevin Conlon

Updated approach to the patient with metastatic melanoma / Rodabe N. Amaria and Rene Gonzalez.

Notes:

Includes bibliographical references and index.

ISBN:

9781936287796

193628779X

9781617051616

1617051616

OCLC:

796759679